Cargando…
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
BACKGROUND: Chloroquine is the first-line treatment for Plasmodium vivax malaria in most endemic countries, but resistance is increasing. Monitoring of antimalarial efficacy is essential, but in P vivax infections the assessment of treatment efficacy is confounded by relapse from the dormant liver s...
Autores principales: | Price, Ric N, von Seidlein, Lorenz, Valecha, Neena, Nosten, Francois, Baird, J Kevin, White, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science ;, The Lancet Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178238/ https://www.ncbi.nlm.nih.gov/pubmed/25213732 http://dx.doi.org/10.1016/S1473-3099(14)70855-2 |
Ejemplares similares
-
Diagnosis and Treatment of Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2016) -
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012) -
Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008) -
Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2016) -
Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
por: Phyo, Aung Pyae, et al.
Publicado: (2011)